Sign In
Buy INO
$1.14
-0.0700 (-5.79%)
At Close: Jun 03, 2026
INOVIO to Participate in Upcoming Investor Conferences in May
08:00am, Monday, 29'th Apr 2024
PLYMOUTH MEETING, Pa. , April 29, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-r
INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024
08:00am, Monday, 29'th Apr 2024
PLYMOUTH MEETING, Pa. , April 29, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-
INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
06:39pm, Monday, 15'th Apr 2024
PLYMOUTH MEETING, Pa. , April 15, 2024 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and pr
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
06:28pm, Tuesday, 26'th Mar 2024
PLYMOUTH MEETING, Pa. , March 26, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-re
Call Traders Swarm Heavily Shorted Pharma Stock
02:18pm, Monday, 11'th Mar 2024
Options bulls are blasting Inovio Pharmaceuticals Inc (NASDAQ:INO) after Jefferies hiked its price target to $8 from $4.50 on Friday.
Does Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?
10:55am, Friday, 08'th Mar 2024
The consensus price target hints at a 122.9% upside potential for Inovio (INO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate r
Inovio Pharmaceuticals, Inc. (INO) Q4 2023 Earnings Call Transcript
08:25pm, Wednesday, 06'th Mar 2024
Inovio Pharmaceuticals, Inc. (NASDAQ:INO ) Q4 2023 Earnings Conference Call March 6, 2024 4:30 PM ET Company Participants Thomas Hong - Manager of Investor Relations Jacqueline Shea - President and Ch
INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
04:05pm, Wednesday, 06'th Mar 2024
Announced substantial progress with lead program, INO-3107, as potential treatment for Recurrent Respiratory Papillomatosis (RRP) Positive data announced from Phase 1/2 trial Orphan Drug Designation
Wall Street Analysts Predict a 146.39% Upside in Inovio (INO): Here's What You Should Know
10:56am, Wednesday, 21'st Feb 2024
The mean of analysts' price targets for Inovio (INO) points to a 146.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts
INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024
08:00am, Wednesday, 21'st Feb 2024
PLYMOUTH MEETING, Pa. , Feb. 21, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-as
Inovio (INO) Moves 17.4% Higher: Will This Strength Last?
07:26am, Monday, 12'th Feb 2024
Inovio (INO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in th
INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
11:46am, Wednesday, 07'th Feb 2024
PLYMOUTH MEETING, Pa. , Feb. 7, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-rela
INOVIO Reports Inducement Grant Under Inducement Plan
08:00am, Friday, 02'nd Feb 2024
PLYMOUTH MEETING, Pa. , Feb. 2, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-re
How Much Upside is Left in Inovio (INO)? Wall Street Analysts Think 223.72%
10:56am, Tuesday, 30'th Jan 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 223.7% in Inovio (INO). While the effectiveness of this highly sought-after metric is questionable, the positiv
Why Is Inovio Pharmaceuticals (INO) Stock Down Today?
09:13am, Wednesday, 24'th Jan 2024
Inovio Pharmaceuticals (NASDAQ: INO ) stock is taking a beating on Wednesday as the biotechnology company prepares for a reverse stock split. The company's shares will undergo a one-for-12 reverse st
